Oxford Brain Diagnostics Advances Vision for Measuring Brain Health and Neurodegenerative Disease with Five New Studies at AAIC 2026
New findings demonstrate the potential of OBD's MRI-based Cortical Disarray Measurement (CDM®) technology to support patient identification, disease characterization, treatment monitoring, and…
Read the full articleYou might also wanna read

Head CT Foundation Model Outperforms Commercial Alternatives, Detects Diseases Beyond Hemorrhage
Photo by Anna Shvets from Pexels The cheap, fast scans that emergency rooms use to check for strokes and brain bleeds may also detect Alzhei

Global consortium releases AI toolbox to unlock new Alzheimer's treatments
The Consortium for Biomedical Research and Artificial Intelligence in Neurodegeneration (C-BRAIN), a global collaboration of academic resear
The Case for Amyloid Centiloid Quantification in Dementia Diagnosis
This Viewpoint discusses using Centiloid values in diagnostic and treatment decisions for patients with mild cognitive impairment or dementi
Advances in Brain-on-a-Chip and BBB-on-a-Chip Models for Neurodegenerative Disease Research
Brain-on-a-chip is a microphysiologic platform that comprises cultured brain cells to understand brain disease pathogenesis and treatment. T
IFM | Innovative Diagnostic Tools and Workflows for Suspected Alzheimer's in Primary Care
In this special edition of Inside Family Medicine , sponsored by Roche Diagnostics, h ost Darren Sextro talks with brain health experts Dean

Científicos españoles logran localizar por primera vez los microtrombos que agravan el alzhéimer
La técnica de imagen médica ofrece una nueva estrategia terapéutica frente a una enfermedad todavía sin cura

Comments
Sign in to join the conversation.
No comments yet. Be the first.